NeoGenomics Inc (NEO) — Capital Reinvestment Ratio
NeoGenomics Inc (NEO) has a Capital Reinvestment Ratio of 0.41x as of June 2026, meaning it reinvests 0% of its operating cash flow ($19.96 Million) in capital expenditures ($8.22 Million). Check NEO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NeoGenomics Inc Capital Reinvestment Ratio (2011–2025)
This chart tracks NeoGenomics Inc's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see NeoGenomics Inc (NEO) cash conversion ratio.
Annual Capital Reinvestment Ratio for NeoGenomics Inc (2011–2025)
Year-by-year Capital Reinvestment Ratio for NeoGenomics Inc from 2011 to 2025. See NeoGenomics Inc (NEO) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 5.16x | $5.23 Million | $27.01 Million | ▼ -11.7% |
| 2024 | 5.85x | $7.02 Million | $41.06 Million | ▼ -70.7% |
| 2020 | 19.93x | $1.46 Million | $29.10 Million | ▲ +2225.2% |
| 2019 | 0.86x | $23.37 Million | $20.03 Million | ▲ +168.2% |
| 2018 | 0.32x | $44.79 Million | $14.31 Million | ▼ -57.9% |
| 2017 | 0.76x | $18.04 Million | $13.69 Million | ▲ +116.3% |
| 2016 | 0.35x | $21.48 Million | $7.54 Million | ▲ +1.3% |
| 2015 | 0.35x | $6.39 Million | $2.21 Million | ▼ -13.2% |
| 2014 | 0.40x | $9.45 Million | $3.77 Million | ▼ -55.8% |
| 2013 | 0.90x | $2.23 Million | $2.01 Million | ▼ -93.1% |
| 2011 | 13.00x | $69.00K | $897.00K | — |